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Abstract 
Growing male rats have been considered and used as a model for bone growth and 
prevention of osteoporosis because of their high bone turnover and demand for calcium. 
Dual Energy X-ray Absorptiometry (DEXA) is a useful tool for identifying minimal 
changes in bone mineral density and has recently been adapted for use in small animal 
models. The objective of this trial was to identify the changes in Bone Mineral Density 
(BMD) in relation to age and to identify how BMD varies from site to site. 
Sixty male Sprague-Dawley rats were split into six groups to allow measurements at 
one, two, three, four, five and six months of age (n=10 per group). At each time point a 
group of rats was scanned using a QDR4000 DEXA machine from Hologic. Duplicate 
BMD measurements were obtained for the whole body, spine and both femurs in vivo. 
The rats were then euthanased and the spine and both femurs were excised for ex vivo 
DEXA scanning and ashed calcium analysis. 
BMD increased almost linearly to four months and then formed a plateau. This indicates 
that from weaning to four months is an especially sensitive time for manipulating bone 
growth in male rats. There was a significant difference in BMD between groups 
(P<0.001), which is to be expected in growing rats. There was also a significant 
difference in BMD within groups (p<0.001), believed to be due to variation at two and 
five months of age. There was a very strong positive correlation between weight and 
BMD and age and BMD at all sites, indicating that BMD is a strongly related to both 
weight and age. All sites were strongly correlated to each other and to the ashed calcium 
values. The excised femur had a lower BMD value than the in vivo femur, although the 
two values were strongly correlated. This is believed to be due to differences in 
positioning and indicates that the two methods cannot be used interchangeably. 
11 
These results indicate that bone mineral density is the gold standard for following 
changes in bone growth over time in the growing rat. Alternatively, ashed bone calcium 
content can be used, but only as a once off endpoint. 
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General Introduction 
Osteoporosis 
Osteoporosis is a wide spread disease in postmenopausal women and the elderly. It 
is estimated that in the U.S.A alone 15-20 million women over the age of 45 have 
osteoporosis (Baran et al, 1989; Petley et al, 1996). Osteoporosis describes a 
condition of low bone mass that results from excessive loss of bone after maturation 
or from inadequate development of the skeleton during maturation. Osteoporosis 
and its consequences have become one of the highest costs to our society 
(Aufdemorte et al, 1993). 
With new advances in science and medicine, the average life expectancy has 
increased. Diseases that were previously fatal are now treated effectively by a range 
of drugs and practices. This has led to an increase in the number of elderly people in 
the population, resulting in an increase in the number of cases of osteoporosis. Loss 
of bone mass is an almost universal occurrence in the elderly and leads to an 
increased risk of fracture (Baran et al, 1989). 
The World Health Organisation (WHO) definition of osteoporosis is "A systemic 
skeletal disease characterised by low bone mass and micro-architectural 
deterioration of bone tissue, with a consequent increase in bone fragility and 
susceptibility to fracture" (Kanis, 1994; Petley et al, 1996)). There is a rapid loss of 
trabeculae in spongy bone and a slower loss in cortical bone. This gives the bone a 
porous look. Although bone mass is decreased, mineralisation of the remaining bone 
is normal. 
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Bone is a living tissue that is constantly being remodelled. This happens in two 
phases. The first is bone resorption. Once activated, osteoclast precursor cells 
clump together and become an active multi-celled unit, which chews through bone. 
Tunnels are formed in cortical bone and lacunae are formed in trabecular bone. This 
process takes about one to three weeks. The osteoclasts then disappear and are 
replaced by osteoblasts. The osteoblast's role is to repair the tunnels and lacunae by 
filling them in with new bone. This process takes several months (Kanis, 1994). In 
healthy young adults the net balance is zero. 
There are two types of osteoporosis, senile and postmenopausal. In senile 
osteoporosis, it appears that the cavities that are formed in bone are only being 
partially filled . This indicates a decrease in bone formation. It is likely that senile 
osteoporosis is a natural part of the aging process. Senile osteoporosis could act 
through an increase in bone resorption, a decrease in bone formation or a 
combination of both factors . Women are affected at a ratio of 2:1 compared to men. 
There are two main reasons for this. Firstly women are smaller in stature than men, 
so they have less bone mass to start with (refer to Figure 1 ). Secondly there is a 
definite hormonal link. The sex hormones have a protective role against the catabolic 
action of Parathyroid Hormone (PTH). Androgens are responsible for skeletal 
integrity in males (Rosen et al, 1995). Testosterone has a higher anabolic effect on 
bone than oestrogen although the levels of both decline with age. The circulating 
levels of estrogen decrease dramatically in women after menopause. 
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Figure 1 Growth of the skeleton 
In postmenopausal osteoporosis, an increase in bone turnover occurs due to a lack 
of oestrogen (Ke et al, 1995). The circulating levels of oestrogen decrease after 
menopause. Oestrogen has an inhibitory effect on PTH , which is known to stimulate 
osteoclasts (Bagi , 1997). In postmenopausal osteoporosis the number of osteoclasts 
present increases. This results in very large cavities forming in the bone. 
Unfortunately there is no subsequent increase in the activity of the osteoblasts. This 
leads to a thinning of the bone's structure, especially in trabecular bone (Kanis, 
1994). 
Secondary osteoporosis may develop as a result of other factors (Nordin, 1984 ). 
Some genetic disorders such as Pagets disease and hypogonadism can lead to 
osteoporosis. Alcoholism and several drug therapies , such as the use of 
glucocorticosteroids, also lead to osteoporosis and increase the risk of fracture (Lore, 
1989). 
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While treatment can increase bone mineral density (BMD), the damage to the 
architectural structure of the bone may never mend completely. The weakening in 
the bone's structure means that fractures may still occur despite positive responses 
in BMD. 
Osteoporosis is a serious medical condition. While brittle bones in themselves do not 
cause a problem , there is a subsequent increase in fracture risk . Low bone density 
increases the risk of a debilitating fracture. A loss of height is the most recognisable 
sign of osteoporosis. In normal cortical bone, 95% of the area is taken up by bone 
material; in osteoporosis as little as 30% of the area may consist of bone (Sissons, 
1962). This gives the bone a porous appearance and can lead to weakening and 
collapse of the bone structure. The lumbar spine is usually the first area to be 
affected , as it has a small area in comparison to its weight bearing capacity. This 
often results in a collapse of the vertebrae and causes a reduction in the patient's 
height. 
The hip is probably the most serious site of fracture and is associated with a higher 
degree of morbidity and mortality (Sissons, 1962). It is usually the result of a fall and 
thin women with little padding around their hips are particularly susceptible. It is 
associated with a high cost to our society, as patients are in need of immediate 
hospitalisation. There is also a loss of mobility and increased pain, which can lead to 
a loss of independence. Patients may need to go into a nursing home or be cared for 
by family members. 
The recommended course of action is a hip replacement. The patient is mobilised 
almost immediately. This stops muscle atrophy, which is associated with a decrease 
in blood supply to the bone. This course of action is usually highly successful (Kanis, 
1994). If left in traction the fracture can heal of it's own accord but long-term 
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immobilisation is linked with a greater loss of bone mass, an undesirable side effect 
in osteoporosis. Hip fracture is unlikely to be a main cause of death. The higher 
degree of mortality is probably associated with patients who are too unhealthy to 
undergo hip replacement surgery or who acquire secondary complications unrelated 
to the actual fracture (Sissons, 1962). 
The risk of osteoporosis can be significantly reduced by: 
1. Maximising the development of high peak bone mass (PBM, see chapter 1.1 .1 ). 
2. Maintaining bone mass after PBM is achieved 
3. Reducing bone loss as much as possible. 
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